financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Reliance, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Reliance, Inc.
Apr 24, 2026 8:29 AM

11:10 AM EDT, 04/24/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We increase our 12-month target by $21 to $358, led by an EV/EBITDA of 11.0x our 2027 EBITDA estimate, a modest premium to Reliance's three-year avg. forward EV/EBITDA of 10.7x. We raise our 2026 EPS estimate by $2.45 to $19.26 and our 2027 EPS forecast by $1.88 to $20.22. Reliance continues to demonstrate operational excellence with 13 consecutive quarters of market share gains, significantly outperforming the broader metals service center industry. Reliance's diversified end market exposure provides resilience, with particular strength in infrastructure, data centers, defense, and energy sectors. Extending mill lead times and tight supply conditions support a favorable pricing environment through 2026. With a strong balance sheet (1.0x net debt-to-EBITDA) and disciplined capital allocation including ongoing share repurchases and a 4% dividend increase RS is well-positioned to capitalize on current market dynamics. However, the valuation at current levels limits near-term upside, supporting our Hold opinion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Molson Coors Beverage Company
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Molson Coors Beverage Company
Aug 5, 2025
11:30 AM EDT, 08/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $7 to $48, based on a 2026 P/E of 8.3x, a justified discount to TAP's 5-year average forward P/E of 11.7x. We lower our...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Cenovus Energy
Research Alert: CFRA Keeps Buy Opinion On Shares Of Cenovus Energy
Aug 5, 2025
11:15 AM EDT, 08/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of CAD 24, up CAD 1, reflects a 4.8x multiple of EV to projected '26 EBITDA, in line with CVE's historical forward average. We cut our...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Pfizer Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Pfizer Inc.
Aug 5, 2025
11:10 AM EDT, 08/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After reviewing Q2 results, we maintain our target price at $28, 9.2x our 2026 EPS estimate, a discount to PFE's historical forward P/E average. We raise our 2025 EPS view...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Canada Goose
Research Alert: CFRA Maintains Hold Opinion On Shares Of Canada Goose
Aug 5, 2025
07:20 AM EDT, 08/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by USD1.00 to USD12.00, based on 15x our FY 26 (Mar.) EPS estimate and below the company's three-year average forward P/E multiple of 17.6x....
Copyright 2023-2026 - www.financetom.com All Rights Reserved